Blood plasma inflammation markers during epileptogenesis in post-status epilepticus rat model for temporal lobe epilepsy

Epilepsia

Volumn 54, Issue 4, 2013, Pages 589-595

  Holtman, Linda ^a   Van Vliet, Erwin A ^a,b   Aronica, Eleonora ^c   Wouters, Diana ^d   Wadman, Wytse J ^a,b   Gorter, Jan A ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d SANQUIN RESEARCH   (Netherlands)

Author keywords

C Reactive protein; Electrical stimulation; Epileptogenesis; IL 1 ; IL 6; Inflammation; Pilocarpine; Plasma

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PILOCARPINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; ELECTROSTIMULATION; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPTIC STATE; EPILEPTOGENESIS; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEPSIS; TEMPORAL LOBE EPILEPSY;

ANIMALS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; ELECTROENCEPHALOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPILEPSY, TEMPORAL LOBE; IMMUNOCHEMISTRY; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MUSCARINIC AGONISTS; PILOCARPINE; RATS; RATS, SPRAGUE-DAWLEY; STATUS EPILEPTICUS;

EID: 84875856472     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12112     Document Type: Article

References (28)

1. Alapirtti T, Rinta S, Hulkkonen J, Makinen R, Keranen T, Peltola J,. (2009) Interleukin-6, interleukin-1 receptor antagonist and interleukin-1beta production in patients with focal epilepsy: a video-EEG study. J Neurol Sci 280: 94-97.
2. Bauer S, Cepok S, Todorova-Rudolph A, Nowak M, Koller M, Lorenz R, Oertel WH, Rosenow F, Hemmer B, Hamer HM,. (2009) Etiology and site of temporal lobe epilepsy influence postictal cytokine release. Epilepsy Res 86: 82-88.
3. Choi J, Min HJ, Shin JS,. (2011) Increased levels of HMGB1 and pro-inflammatory cytokines in children with febrile seizures. J Neuroinflammation 8: 135.
4. Fabene PF, Navarro Mora G, Martinello M, Rossi B, Merigo F, Ottoboni L, Bach S, Angiari S, Benati D, Chakir A, Zanetti L, Schio F, Osculati A, Marzola P, Nicolato E, Homeister JW, Xia L, Lowe JB, McEver RP, Osculati F, Sbarbati A, Butcher EC, Constantin G,. (2008) A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med 14: 1377-1383.
5. Gorter JA, van Vliet EA, Aronica E, Lopes da Silva FH,. (2001) Progression of spontaneous seizures after status epilepticus is associated with mossy fibre sprouting and extensive bilateral loss of hilar parvalbumin and somatostatin-immunoreactive neurons. Eur J Neurosci 13: 657-669.
6. Gorter JA, van Vliet EA, Aronica E, Breit T, Rauwerda H, Lopes da Silva FH, Wadman WJ,. (2006) Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy. J Neurosci 26: 11083-11110.
7. Jamali S, Bartolomei F, Robaglia-Schlupp A, Massacrier A, Peragut JC, Regis J, Dufour H, Ravid R, Roll P, Pereira S, Royer B, Roeckel-Trevisiol N, Fontaine M, Guye M, Boucraut J, Chauvel P, Cau P, Szepetowski P,. (2006) Large-scale expression study of human mesial temporal lobe epilepsy: evidence for dysregulation of the neurotransmission and complement systems in the entorhinal cortex. Brain 129: 625-641.
8. Kamm K, Vanderkolk W, Lawrence C, Jonker M, Davis AT,. (2006) The effect of traumatic brain injury upon the concentration and expression of interleukin-1beta and interleukin-10 in the rat. J Trauma 60: 152-157.
9. Lehtimaki KA, Keranen T, Huhtala H, Hurme M, Ollikainen J, Honkaniemi J, Palmio J, Peltola J,. (2004) Regulation of IL-6 system in cerebrospinal fluid and serum compartments by seizures: the effect of seizure type and duration. J Neuroimmunol 152: 121-125.
10. Lehtimaki KA, Keranen T, Palmio J, Makinen R, Hurme M, Honkaniemi J, Peltola J,. (2007) Increased plasma levels of cytokines after seizures in localization-related epilepsy. Acta Neurol Scand 116: 226-230.
11. Lehtimaki KA, Liimatainen S, Peltola J, Arvio M,. (2011) The serum level of interleukin-6 in patients with intellectual disability and refractory epilepsy. Epilepsy Res 95: 184-187.
12. Liimatainen S, Fallah M, Kharazmi E, Peltola M, Peltola J,. (2009) Interleukin-6 levels are increased in temporal lobe epilepsy but not in extra-temporal lobe epilepsy. J Neurol 256: 796-802.
13. Marchi N, Oby E, Batra A, Uva L, De Curtis M, Hernandez N, Van Boxel-Dezaire A, Najm I, Janigro D,. (2007) In vivo and in vitro effects of pilocarpine: relevance to ictogenesis. Epilepsia 48: 1934-1946.
14. Marchi N, Fan Q, Ghosh C, Fazio V, Bertolini F, Betto G, Batra A, Carlton E, Najm I, Granata T, Janigro D,. (2009) Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol Dis 33: 171-181.
15. Marchi N, Granata T, Freri E, Ciusani E, Ragona F, Puvenna V, Teng Q, Alexopolous A, Janigro D,. (2011a) Efficacy of anti-inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics. PLoS ONE 6: e18200.
16. Marchi N, Johnson AJ, Puvenna V, Johnson HL, Tierney W, Ghosh C, Cucullo L, Fabene PF, Janigro D,. (2011b) Modulation of peripheral cytotoxic cells and ictogenesis in a model of seizures. Epilepsia 52: 1627-1634.
17. Pedersen BK, Febbraio MA,. (2008) Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 88: 1379-1406.
18. Peltola J, Palmio J, Korhonen L, Suhonen J, Miettinen A, Hurme M, Lindholm D, Keranen T,. (2000) Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures. Epilepsy Res 41: 205-211.
19. Peltola J, Laaksonen J, Haapala AM, Hurme M, Rainesalo S, Keranen T,. (2002) Indicators of inflammation after recent tonic-clonic epileptic seizures correlate with plasma interleukin-6 levels. Seizure 11: 44-46.
20. Pepys MB, Hirschfield GM,. (2003) C-reactive protein: a critical update. J Clin Invest 111: 1805-1812.
21. Prync AE, Arzt E, Fernandez Castelo S, Finkielman S, Nahmod V,. (1992) The inhibitory effect of the muscarinic agonist pilocarpine on lymphocyte activation involves the IL-2 pathway and the increase in suppressor cell function. Int J Neurosci 62: 277-285.
22. Ravizza T, Gagliardi B, Noe F, Boer K, Aronica E, Vezzani A,. (2008) Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 29: 142-160.
23. Scheiermann P, Hoegl S, Hofstetter C, Pfeilschifter J, Zwissler B, Muhl H, Boost KA, Scheller B,. (2011) Comparing hemodynamics, blood gas analyses and proinflammatory cytokines in endotoxemic and severely septic rats. Int Immunopharmacol 11: 719-723.
24. Tomoum HY, Badawy NM, Mostafa AA, Harb MY,. (2007) Plasma interleukin-1beta levels in children with febrile seizures. J Child Neurol 22: 689-692.
25. Tuttolomondo A, Di Sciacca R, Di Raimondo D, Renda C, Pinto A, Licata G,. (2009) Inflammation as a therapeutic target in acute ischemic stroke treatment. Curr Top Med Chem 9: 1240-1260.
26. Vezzani A, French J, Bartfai T, Baram TZ,. (2011) The role of inflammation in epilepsy. Nat Rev Neurol 7: 31-40.
27. Virta M, Hurme M, Helminen M,. (2002) Increased plasma levels of pro- and anti-inflammatory cytokines in patients with febrile seizures. Epilepsia 43: 920-923.
28. Zattoni M, Mura ML, Deprez F, Schwendener RA, Engelhardt B, Frei K, Fritschy JM,. (2011) Brain infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy. J Neurosci 31: 4037-4050.